APVO vs GILD: Which Stock is Better?
Side-by-side comparison of Aptevo Therapeutics Inc and Gilead Sciences Inc in 2026
APVO
Aptevo Therapeutics Inc
$4.42
GILD
Gilead Sciences Inc
$144.99
Key Metrics Comparison
| Metric | APVO | GILD | Winner |
|---|---|---|---|
| Market Cap | $6.90M | $179.99B | GILD |
| P/E Ratio | 0.00 | 21.35 | APVO |
| EPS (TTM) | $7758.20 | $6.79 | APVO |
| Revenue Growth | -1.0% | 0.0% | GILD |
| Gross Margin | 0.0% | 78.8% | GILD |
Analyze APVO
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is APVO or GILD a better investment?
Comparing APVO and GILD: Aptevo Therapeutics Inc has a market cap of $6.90M while Gilead Sciences Inc has $179.99B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between APVO and GILD?
APVO (Aptevo Therapeutics Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: APVO or GILD?
Based on P/E ratios, APVO trades at a lower multiple (0.0x vs 21.4x).
Which is growing faster: APVO or GILD?
GILD has higher revenue growth at 0.0% vs -1.0% for APVO.
Which company is more profitable: APVO or GILD?
Gilead Sciences Inc (GILD) has higher gross margins at 78.8% compared to 0.0% for APVO.
Which is the larger company: APVO or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $179.99B compared to $6.90M for APVO.
Should I buy APVO or GILD in 2026?
Both APVO and GILD have investment merit. APVO trades at $4.42 while GILD trades at $144.99. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between APVO and GILD stock?
Key differences: Market Cap ($6.90M vs $179.99B), P/E Ratio (0.0x vs 21.4x), Revenue Growth (-1.0% vs 0.0%), Gross Margin (0.0% vs 78.8%).